Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea.

Selam MihreteabLucien PlatonAraia BerhaneBarbara H StokesMarian WarsamePascal CampagneAlexis CriscuoloLaurence MaNathalie PetiotCécile Doderer-LangEric LegrandKurt E WardAssefash Zehaie KassahunPascal RingwaldDavid A FidockDidier Ménard

Published in: The New England journal of medicine (2023)

in Eritrea threaten to compromise regional malaria control and elimination campaigns. (Funded by the Bill and Melinda Gates Foundation and others; Australian New Zealand Clinical Trials Registry numbers, ACTRN12618001223224, ACTRN12618000353291, and ACTRN12619000859189.).

Keyphrases

plasmodium falciparum
clinical trial
risk factors
randomized controlled trial
phase ii
study protocol